474 related articles for article (PubMed ID: 19550323)
1. Variation in paraoxonase-1 activity and atherosclerosis.
Soran H; Younis NN; Charlton-Menys V; Durrington P
Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
4. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
5. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
James RW; Deakin SP
Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
[TBL] [Abstract][Full Text] [Related]
6. Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats.
Trudel K; Sinnett D; James RW; Delvin E; Amre D; Seidman E; Levy E
J Cell Biochem; 2005 Oct; 96(2):404-11. PubMed ID: 16052486
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonases role in the prevention of cardiovascular diseases.
Rosenblat M; Aviram M
Biofactors; 2009; 35(1):98-104. PubMed ID: 19319852
[TBL] [Abstract][Full Text] [Related]
8. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
Soran H; Schofield JD; Liu Y; Durrington PN
Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
[TBL] [Abstract][Full Text] [Related]
9. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
10. [The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis].
Tomás M; Latorre G; Sentí M; Marrugat J
Rev Esp Cardiol; 2004 Jun; 57(6):557-69. PubMed ID: 15225502
[TBL] [Abstract][Full Text] [Related]
11. Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes.
Ikeda Y; Inoue M; Suehiro T; Arii K; Kumon Y; Hashimoto K
Acta Diabetol; 2009 Sep; 46(3):239-42. PubMed ID: 18830558
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion.
Aviram M; Vaya J
Curr Opin Lipidol; 2013 Aug; 24(4):339-44. PubMed ID: 23508039
[TBL] [Abstract][Full Text] [Related]
13. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
Rozenberg O; Aviram M
Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
[TBL] [Abstract][Full Text] [Related]
14. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
15. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.
Deakin SP; James RW
Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase activity in patients with erectile dysfunction.
Ciftci H; Yeni E; Savas M; Verit A; Celik H
Int J Impot Res; 2007; 19(5):517-20. PubMed ID: 17554394
[TBL] [Abstract][Full Text] [Related]
17. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
[TBL] [Abstract][Full Text] [Related]
18. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
Li WF; Sun CW; Cheng TJ; Chang KH; Chen CJ; Wang SL
Toxicol Appl Pharmacol; 2009 Apr; 236(2):246-53. PubMed ID: 19371607
[TBL] [Abstract][Full Text] [Related]
19. Modulation of paraoxonase (PON1) activity.
Costa LG; Vitalone A; Cole TB; Furlong CE
Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
[TBL] [Abstract][Full Text] [Related]
20. Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?
Reddy ST; Devarajan A; Bourquard N; Shih D; Fogelman AM
Curr Opin Lipidol; 2008 Aug; 19(4):405-8. PubMed ID: 18607188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
